Advertisement
Research Article

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial

  • Abdou Amza,

    Affiliation: Programme National de Lutte Contre la Cecité, Niamey, Niger

    X
  • Boubacar Kadri,

    Affiliation: Programme National de Lutte Contre la Cecité, Niamey, Niger

    X
  • Baido Nassirou,

    Affiliation: Programme National de Lutte Contre la Cecité, Niamey, Niger

    X
  • Nicole E. Stoller,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Sun N. Yu,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Zhaoxia Zhou,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Stephanie Chin,

    Affiliation: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America

    X
  • Sheila K. West,

    Affiliation: Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States of America

    X
  • Robin L. Bailey,

    Affiliation: Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • David C. W. Mabey,

    Affiliation: Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

    X
  • Jeremy D. Keenan,

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America

    X
  • Travis C. Porco,

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America, Center for Infectious Disease and Emergency Readiness, University of California, Berkeley, California, United States of America

    X
  • Thomas M. Lietman,

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America, Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America

    X
  • Bruce D. Gaynor mail,

    bruce.gaynor@ucsf.edu

    Affiliations: F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America, Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America

    X
  • for the PRET Partnership
  • Published: April 24, 2012
  • DOI: 10.1371/journal.pntd.0001586

About the Authors

Abdou Amza, Boubacar Kadri, Baido Nassirou
Programme National de Lutte Contre la Cecité, Niamey, Niger
Nicole E. Stoller, Sun N. Yu, Zhaoxia Zhou, Stephanie Chin, Jeremy D. Keenan, Travis C. Porco, Thomas M. Lietman, Bruce D. Gaynor
F.I. Proctor Foundation, University of California San Francisco, San Francisco, California, United States of America
Sheila K. West
Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, United States of America
Robin L. Bailey, David C. W. Mabey
Clinical Research Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
Jeremy D. Keenan, Thomas M. Lietman, Bruce D. Gaynor
Department of Ophthalmology, University of California San Francisco, San Francisco, California, United States of America
Travis C. Porco, Thomas M. Lietman
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America
Travis C. Porco, Thomas M. Lietman
Institute for Global Health, University of California San Francisco, San Francisco, California, United States of America
Travis C. Porco
Center for Infectious Disease and Emergency Readiness, University of California, Berkeley, California, United States of America

Corresponding Author

Email: bruce.gaynor@ucsf.edu

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: SKW RLB DCWM JDK TCP TML BDG. Performed the experiments: AA BK BN NES SNY ZZ SC JDK TML BDG. Analyzed the data: ZZ SC JDK TCP TML BDG. Contributed reagents/materials/analysis tools: ZZ SC TML BDG. Wrote the paper: AA NES SNY JDK TCP TML BDG.